BioRestorative Therapies (NASDAQ:BRTX) Trading 3.6% Higher – Should You Buy?

BioRestorative Therapies, Inc. (NASDAQ:BRTX)’s share price traded up 3.6% during mid-day trading on Tuesday . The company traded as high as $1.68 and last traded at $1.60. 65,711 shares traded hands during mid-day trading, a decline of 90% from the average session volume of 666,135 shares. The stock had previously closed at $1.54.

BioRestorative Therapies Stock Performance

The company has a market capitalization of $11.04 million, a PE ratio of -1.04 and a beta of 64.37. The company’s 50-day moving average is $1.96 and its 200 day moving average is $1.71.

Institutional Investors Weigh In On BioRestorative Therapies

An institutional investor recently bought a new position in BioRestorative Therapies stock. Citadel Advisors LLC bought a new stake in shares of BioRestorative Therapies, Inc. (NASDAQ:BRTX) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 21,481 shares of the company’s stock, valued at approximately $31,000. Citadel Advisors LLC owned about 0.31% of BioRestorative Therapies at the end of the most recent quarter. 69.38% of the stock is currently owned by institutional investors and hedge funds.

About BioRestorative Therapies

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.